January 20, 2025 - 22:43

A large new study has shed light on the wider health impacts of taking Ozempic-style drugs. These medications, primarily used for managing type 2 diabetes and aiding weight loss, have been found to be associated with over 60 health benefits and risks. The research is considered one of the most comprehensive analyses of these drugs to date, providing valuable insights into their effects on various bodily systems.
Among the reported benefits, participants experienced significant weight loss, improved blood sugar control, and enhanced cardiovascular health. However, the study also highlighted potential risks, including gastrointestinal issues, thyroid tumors, and other metabolic concerns. Researchers emphasized the importance of monitoring patients closely while on these medications, as the balance between benefits and risks can vary widely among individuals.
As the popularity of Ozempic-style drugs continues to rise, this study serves as a crucial resource for healthcare providers and patients alike, fostering informed discussions about their use and long-term implications on health.
May 14, 2026 - 23:22
Kate Marmion School of Public Health celebrates gift and inaugural graduating class - UT Health San AntonioThe University of Texas at San Antonio held a ceremony on Wednesday, May 13, to officially name the Kate Marmion School of Public Health. The event honored a $30 million transformational gift from...
May 14, 2026 - 11:14
Minnesota readies first-ever K-12 health education standardsAdvocates say the new standards, set to be phased in over the next three years, introduce needed guidance on nutrition, first aid, sex education, and abuse prevention. Some school watchers worry...
May 13, 2026 - 19:53
From Zambia to Harvard: How Chimba Sanga Is Fighting HIV and TB With New SkillsChimba Sanga, a physician and public health leader from Zambia, is bringing his Harvard training back home to tackle two of the country`s deadliest diseases. Sanga, currently a Master of Public...
May 13, 2026 - 01:07
AP report: Marty Makary resigning as Trump's FDA chiefMarty Makary is resigning as head of the Food and Drug Administration, according to an Associated Press report. His departure comes after a turbulent tenure marked by deep internal discord and a...